FDA.reportPublic FDA data

Wilms tumour protein IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of Wilms tumour protein, a transcription factor encoded by the Wilms tumour 1 gene or WT1 gene, in a clinical specimen.
GUDID devices
2
Last updated
2026-06-04 19:44:10

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
B502BSB60350WT1 control slidesBIO SB, INC.Control Slides, 52020-06-01
B502BSB9429CS0WT1 Control SlidesBIO SB, INC.BSB-9429-CS2025-03-18